Bryn Mawr Trust CO Argenx Se Transaction History
Bryn Mawr Trust CO
- $4.09 Billion
- Q3 2025
A detailed history of Bryn Mawr Trust CO transactions in Argenx Se stock. As of the latest transaction made, Bryn Mawr Trust CO holds 336 shares of ARGX stock, worth $305,081. This represents 0.01% of its overall portfolio holdings.
Number of Shares
336
Previous 2,126
84.2%
Holding current value
$305,081
Previous $1.57 Million
84.25%
% of portfolio
0.01%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding ARGX
# of Institutions
525Shares Held
26MCall Options Held
589KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...